When it comes to metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), early diagnosis is key. In this video, learn how doctors diagnosis MASLD and MASH, according to Alyson Fox, MD, MSCE, Transplant Hepatologist at Columbia University’s Irving Medical Center.
Alyson Fox, MD, is the Medical Director of the Adult Liver Transplant Program at Columbia University’s Irving Medical Center. She specializes in a variety of liver conditions, including viral hepatitis, alcohol-related liver disease, metabolic dysfunction-associated steatotic liver disease, and liver cancer.
References
American Academy of Family Physicians. (2024). Nonalcoholic fatty liver disease (metabolic dysfunction-associated steatotic liver disease).
Likhitsup, A. (2024). Metabolic dysfunction-associated steatotic liver disease (MASLD). American College of Gastroenterology.
National Institute of Diabetes and Digestive and Kidney Diseases. (2021). Definition & facts of NAFLD & NASH.
Sharma, B., et al. (2023). Nonalcoholic steatohepatitis. StatPearls.
Why trust our experts?


